Rocuronium Injection, Solution
Product Images NDC 63323-426

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 63323-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Roc04 0004 01

FDA Label Image

Roc04 0004 02

FDA Label Image

Roc04 0004 03

FDA Label Image

Roc04 0004 04

FDA Label Image

Roc04 0004 05

FDA Label Image

Roc04 0004 06

This is a warning label for a medication called Rocuronium Bromide Injection, which is to be used intravenously. The medication is a paralyzing agent and can cause respiratory arrest. Facilities with equipment for artificial respiration must be immediately available. Each 5mL vial contains 10mg of Rocuronium Bromide, 2mg of sodium acetate, and is sterile and nonpyrogenic. The medication should be stored at 2-8°C and not frozen, with opened vials to be used within 30 days and unopened vials to be used within 60 days of removal from refrigeration. Usual dosage information is contained in the package insert.*

FDA Label Image

Roc04 0004 07

This is a prescription drug called Rocuronium Bromide Injection which is used for intravenous use. It is packed in 10x5mL multiple dose vials and should be stored at a temperature between 2°C to 8°C (36°F to 46°F). The drug must not be frozen and should be used within 60 days upon removal from refrigeration to room temperature. The container closure does not contain natural rubber latex. The drug is a paralyzing agent and can cause respiratory arrest, so artificial respiration facilities must be available immediately. Usual dosage information can be found on the package insert.*

FDA Label Image

Roc04 0004 08

This text describes a medication with the NDC code 63323-426-01, which is Rocuronium Bromide Injection supplied as a 10 mL multiple-dose vial containing 100 mg per 10 mL (10 mg per mL). It includes warnings about respiratory arrest due to the paralyzing agent and advises that facilities for artificial respiration must be immediately available. The medication is to be administered intravenously and is sterile, nonpyrogenic. The medication should be stored between 2° and 8°C and should not be frozen. Opened vials should be used within 30 days and those removed from refrigeration to room temperature should be used within 60 days.*

FDA Label Image

Roc04 0004 09

This is a description of a drug called Rocuronium Bromide Injection, used for intravenous use. Each container contains 10mg Rocuronium Bromide and 2mg Sodium Acetate, and is adjusted to a isotonic solution with NeCland. It is essential to have artificial respiration available for use in case of emergency as it is a paralyzing agent. This injection should be stored at 2° to 6°C. It is not recommended to use the opened vials beyond 30 days. The container closure does not contain natural rubber latex.*

FDA Label Image

Roc04 0004 10

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.